345 related articles for article (PubMed ID: 31579913)
21. Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival.
Li Y; Qi D; Zhu B; Ye X
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540684
[TBL] [Abstract][Full Text] [Related]
22. Genetic variants in circTUBB interacting with smoking can enhance colorectal cancer risk.
Zhang K; Li S; Gu D; Xu K; Zheng R; Xin J; Meng Y; Ben S; Chu H; Zhang Z; Shu Y; Du M; Liu L; Wang M
Arch Toxicol; 2020 Jan; 94(1):325-333. PubMed ID: 31797002
[TBL] [Abstract][Full Text] [Related]
23. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
[TBL] [Abstract][Full Text] [Related]
24. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
25. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
Li Z; Li F; Peng Y; Fang J; Zhou J
Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856
[TBL] [Abstract][Full Text] [Related]
26. Genetic Modulation of BET1L Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m6A Modification.
Li S; Du M; Xu K; Ben S; Zhu T; Guo M; Xin J; Zhu L; Gu D; Zhang Z; Wang M
Cancer Res; 2023 Jul; 83(13):2142-2154. PubMed ID: 37115853
[TBL] [Abstract][Full Text] [Related]
27. In silico genome-wide identification of m6A-associated SNPs as potential functional variants for periodontitis.
Lin W; Xu H; Wu Y; Wang J; Yuan Q
J Cell Physiol; 2020 Feb; 235(2):900-908. PubMed ID: 31245852
[TBL] [Abstract][Full Text] [Related]
28. m6AVar: a database of functional variants involved in m6A modification.
Zheng Y; Nie P; Peng D; He Z; Liu M; Xie Y; Miao Y; Zuo Z; Ren J
Nucleic Acids Res; 2018 Jan; 46(D1):D139-D145. PubMed ID: 29036329
[TBL] [Abstract][Full Text] [Related]
29. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
30. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome-wide analysis of N6-methyladenosine uncovers its regulatory role in gene expression in the lepidopteran Bombyx mori.
Li B; Wang X; Li Z; Lu C; Zhang Q; Chang L; Li W; Cheng T; Xia Q; Zhao P
Insect Mol Biol; 2019 Oct; 28(5):703-715. PubMed ID: 30957943
[TBL] [Abstract][Full Text] [Related]
32. Genome-Wide Identification of
Chen Y; Shen M; Ji C; Huang Y; Shi Y; Ji L; Qin Y; Gu Y; Fu Q; Chen H; Xu K; Yang T
Front Endocrinol (Lausanne); 2022; 13():913345. PubMed ID: 35784577
[TBL] [Abstract][Full Text] [Related]
33. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis.
Zhang X; Zhang S; Yan X; Shan Y; Liu L; Zhou J; Kuang Q; Li M; Long H; Lai W
J Cell Mol Med; 2021 Apr; 25(7):3634-3645. PubMed ID: 33724691
[TBL] [Abstract][Full Text] [Related]
34. Epitranscriptomics: Correlation of N6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats.
Fu Y; Zorman B; Sumazin P; Sanna PP; Repunte-Canonigo V
PLoS One; 2019; 14(1):e0203566. PubMed ID: 30653517
[TBL] [Abstract][Full Text] [Related]
35. N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential.
Yang D; Qiao J; Wang G; Lan Y; Li G; Guo X; Xi J; Ye D; Zhu S; Chen W; Jia W; Leng Y; Wan X; Kang J
Nucleic Acids Res; 2018 May; 46(8):3906-3920. PubMed ID: 29529255
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
[TBL] [Abstract][Full Text] [Related]
38. Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Colon Cancer.
Huang L; Zhu J; Kong W; Li P; Zhu S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670062
[TBL] [Abstract][Full Text] [Related]
39. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
40. Genetic variants in N6-methyladenosine are associated with bladder cancer risk in the Chinese population.
Liu H; Gu J; Jin Y; Yuan Q; Ma G; Du M; Ge Y; Qin C; Lv Q; Fu G; Wang M; Chu H; Yuan L; Zhang Z
Arch Toxicol; 2021 Jan; 95(1):299-309. PubMed ID: 32964246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
